Leslie Trigg

Leslie Trigg brings over 25 years of leadership experience in the healthcare and medical device industries. She is President and Chief Executive Officer of Outset Medical, Inc. (Nasdaq: OM), a dialysis-focused medical device company, and has served as Chair of its Board of Directors since 2022. Previously, Ms. Trigg was an Executive in Residence at Warburg Pincus LLC, a private equity firm. Her executive roles have included leadership positions at Lutonix, Inc. (acquired by CR Bard), AccessClosure, Inc. (acquired by Cardinal Health), and FoxHollow Technologies, Inc. (acquired by ev3/Covidien). She also held earlier roles at Cytyc Corporation, Pro-Duct Health, Inc., and Guidant Corporation.

Ms. Trigg holds a Bachelor of Science in Communications from Northwestern University and an MBA from the Haas School of Business at the University of California, Berkeley. She currently serves as Chair of the Board of Directors for the Medical Device Manufacturers Association (MDMA). Her deep expertise in leadership, strategy, governance, and M&A brings valuable insight to our Board of Directors.